With regard to the analysis of laboratory parameters, the eosinophil count had a slightly significant increase at T4 (median 460 cells/mm 3 ) followed by a decrease at T8 (median 400 cells/mm 3 ) and T12 (median 370 cells/mm 3 ) in agreement with dupilumab registration and real-life studies [ 28 , 29 ].
← all excerpts
Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis.
1
—
—